首页> 外文期刊>The Canadian journal of cardiology >The first case of takotsubo cardiomyopathy associated with sodium tetradecyl sulphate sclerotherapy.
【24h】

The first case of takotsubo cardiomyopathy associated with sodium tetradecyl sulphate sclerotherapy.

机译:takotsubo心肌病的第一例与十四烷基硫酸钠硬化疗法有关。

获取原文
获取原文并翻译 | 示例
           

摘要

The present article describes the case of a 70-year-old woman who developed a classic type takotsubo cardiomyopathy after receiving cosmetic sclerotherapy for varicose veins of the legs with sodium tetradecyl sulphate (STS) injections. The patient was in her usual state of health before the injections, and described no apprehension leading up to the procedure and no pain during the procedure. However, a few minutes after the completion of the procedure, the patient had severe chest pain of sudden onset and an electrocardiogram highly suggestive of ST elevation myocardial infarction. The patient was referred for emergent coronary angiography, which was normal. Subsequent ventriculography confirmed the suspected apical ballooning typical of takotsubo cardiomyopathy. Ventricular function returned to near-normal within three days of presentation. The present article describes what is believed to be the first case of takotsubo cardiomyopathy associated with the use of STS. A review of adverse events ascribed to STS revealed visual disturbances and transient ischemic attacks, suggesting the possibility of a common underlying vasospastic pathophysiology and an under- recognized vasoactive potential of STS that merits further investigation. In the interim, the present case advocates for the recommendation of universal pretreatment test dosing.
机译:本文介绍了一名70岁女性的案例,该女性在接受十四烷基硫酸钠(STS)注射对腿部静脉曲张进行化妆品硬化治疗后发展出经典型takotsubo心肌病。病人在注射之前处于正常的健康状态,并且没有对手术造成忧虑,在手术过程中也没有疼痛。然而,在手术完成后几分钟,患者突然起病,出现严重的胸痛,心电图强烈提示ST段抬高型心肌梗塞。该患者转诊为急诊冠状动脉造影,正常。随后的心室造影证实了takotsubo心肌病典型的可疑的根尖膨胀。出现后三天内,心室功能恢复至接近正常。本文介绍了被认为是与使用STS相关的takotsubo心肌病的首例病例。对归因于STS的不良事件的回顾揭示了视觉障碍和短暂性缺血发作,表明可能存在常见的潜在血管痉挛病理生理学和STS血管活性潜力未得到充分认识的可能性,值得进一步研究。在此期间,本案提倡通用预处理测试剂量的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号